GROOVE BOTANICALS, INC. (GRVE) earnings per share
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-03-31 | -$0.01 | 2025-07-16 |
| FY 2024 | 2024-03-31 | -$0.01 | 2024-08-15 |
| FY 2024 | 2023-03-31 | $0.00 | 2024-08-15 |
| FY 2016 | 2016-03-31 | — | 2018-08-28 |
| FY 2014 | 2015-03-31 | — | 2015-08-14 |
| FY 2013 | 2014-03-31 | — | 2014-09-30 |
| FY 2012 | 2013-03-31 | — | 2013-08-20 |
| FY 2011 | 2012-03-31 | — | 2012-07-13 |
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q3 2026 | 2025-12-31 | $0.00 | 2026-02-20 |
| Q2 2026 | 2025-09-30 | $0.00 | 2025-11-19 |
| Q1 2026 | 2025-06-30 | $0.00 | 2025-08-19 |
| Q4 2025 | 2025-03-31 | -$0.01 | 2025-07-16 |
| Q3 2025 | 2024-12-31 | $0.00 | 2025-02-25 |
| Q2 2025 | 2024-09-30 | $0.00 | 2024-11-14 |
| Q1 2024 | 2024-06-30 | $0.00 | 2024-08-22 |
| Q4 2024 | 2024-03-31 | -$0.01 | 2024-08-15 |
| Q3 2023 | 2023-12-31 | $0.00 | 2024-02-14 |
| Q2 2023 | 2023-09-30 | $0.00 | 2024-01-11 |
| Q2 2023 | 2023-06-30 | $0.00 | 2024-01-11 |
| Q4 2024 | 2023-03-31 | $0.00 | 2024-08-15 |
| Q3 2023 | 2022-12-31 | $0.00 | 2024-02-14 |
| Q2 2023 | 2022-09-30 | $0.00 | 2024-01-11 |
| Q3 2018 | 2017-12-31 | -$0.00 | 2019-04-25 |
| Q2 2018 | 2017-09-30 | -$0.01 | 2019-04-25 |
| Q1 2018 | 2017-06-30 | -$0.01 | 2019-04-25 |
| Q3 2017 | 2016-12-31 | -$0.01 | 2019-01-11 |
| Q2 2017 | 2016-09-30 | -$0.01 | 2019-01-11 |
| Q1 2017 | 2016-06-30 | -$0.01 | 2019-01-11 |
| Q4 2016 | 2016-03-31 | — | 2018-08-28 |
| Q3 2015 | 2015-12-31 | -$0.01 | 2016-02-23 |
| Q2 2015 | 2015-09-30 | -$0.01 | 2015-11-23 |
| Q1 2015 | 2015-06-30 | $0.00 | 2015-09-10 |
| Q4 2014 | 2015-03-31 | — | 2015-08-14 |
| Q3 2014 | 2014-12-31 | $0.01 | 2015-07-02 |
| Q2 2014 | 2014-09-30 | -$0.01 | 2015-05-18 |
| Q1 2014 | 2014-06-30 | -$0.01 | 2014-11-04 |
| Q4 2013 | 2014-03-31 | — | 2014-09-30 |
| Q3 2013 | 2013-12-31 | -$0.06 | 2014-04-07 |
| Period | End | FCF / Share | Filed |
|---|---|---|---|
| Q3 2014 | 2014-12-31 | -$0.01 | 2015-07-02 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from
the matching 10-Q; Q4 is derived as full-year minus nine-month
YTD because XBRL doesn't tag Q4 as its own period.
EPS Basic and EPS Diluted
are reported directly by the filer.
FCF / Share is computed as
(Operating Cash Flow − Capital Expenditures) ÷ Diluted
Shares Outstanding. When SEC companyfacts omits the
direct diluted-share concept for an older period, we
imply it from NetIncomeLoss ÷ EarningsPerShareDiluted.
For financial filers whose operating cash flow includes
customer-fund activity (e.g. Mercado Pago deposits),
FCF may materially exceed net income because the fintech
float is recorded inside OCF under US GAAP.
Per-share values are split-adjusted
to the current share count (3 split
s since
2000).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
GRVE CIK 0000918573 Source: EDGAR filings · all facts